Stock listing

NASDAQ:TRBN Trubion Pharmaceuticals Inc Stock

Follow Trubion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:TRBN

$4.60 USD

Close on Oct 28, 2010 · No longer trades

Oct 18, 2006 to last close -64.9% · weekly closes, Oct 18, 2006 – Oct 28, 2010
Lowest – highest close
$1.01 – $21.99 USDSince Oct 18, 2006 · lowest Dec 9, 2008 · highest Feb 5, 2007

Delisted NASDAQ:TRBN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TRBN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Trubion Pharmaceuticals Inc on 6ix

Decks
2 decks · latest Aug 24, 2010

Decks

DeckKindSlidesDate
Merger or Acquisition (August 2010)Merger or acquisition33 slidesAug 24, 2010
Merger or Acquisition (August 2010)Merger or acquisition14 slidesAug 19, 2010

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Bencich
Other companies: AEON Biopharma, Inc. (Chief Financial Officer - · Since at least Apr 1, 2026); Achieve Life Sciences, Inc. (CEO, Director · Aug 11, 2014 – Aug 16, 2024 · Past)
V.P. and CFO · Nov 16, 2009 – Oct 28, 2010 · Past
Scott Stromatt
Other companies: CTi Biopharma Corp (EVP,Clinical Dev & Reg Affair · Jun 20, 2006 – Apr 4, 2008 · Past)
SVP and Chief Medical Officer · Mar 10, 2009 – Oct 28, 2010 · Past
Daniel J BurgeChief Medical Officer, SVP · Mar 12, 2008 – Mar 12, 2008 · Past
David A MannDirector · Oct 17, 2006 – Oct 28, 2010 · Past

Open People

Log in to ask 6ix AI your own questions about Trubion Pharmaceuticals Inc.